Paul Meier

100.9k total citations · 2 hit papers
78 papers, 43.2k citations indexed

About

Paul Meier is a scholar working on Statistics and Probability, Parasitology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paul Meier has authored 78 papers receiving a total of 43.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Statistics and Probability, 11 papers in Parasitology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paul Meier's work include Toxoplasma gondii Research Studies (11 papers), Statistical Methods in Clinical Trials (8 papers) and Herpesvirus Infections and Treatments (5 papers). Paul Meier is often cited by papers focused on Toxoplasma gondii Research Studies (11 papers), Statistical Methods in Clinical Trials (8 papers) and Herpesvirus Infections and Treatments (5 papers). Paul Meier collaborates with scholars based in United States, Vietnam and Guatemala. Paul Meier's co-authors include Edward L. Kaplan, Theodore Karrison, Richard P. Porreco, Charles N. Swisher, Rima McLeod, Nancy Roizen, Donald Ferguson, Kenneth M. Boyer, Christian R. Klimt and Genell L. Knatterud and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Paul Meier

75 papers receiving 41.8k citations

Hit Papers

Nonparametric Estimation from Incomplete Observations 1958 2026 1980 2003 1958 1958 10.0k 20.0k 30.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Meier United States 34 11.7k 10.0k 9.7k 6.6k 5.0k 78 43.2k
Edward L. Kaplan United States 61 11.6k 1.0× 10.7k 1.1× 10.2k 1.1× 6.5k 1.0× 8.8k 1.8× 229 54.4k
Nathan Mantel United States 47 7.8k 0.7× 6.2k 0.6× 6.1k 0.6× 4.1k 0.6× 4.3k 0.9× 285 49.1k
N. E. Breslow United States 56 6.1k 0.5× 5.8k 0.6× 4.5k 0.5× 3.6k 0.5× 3.9k 0.8× 111 40.1k
Julian Peto United Kingdom 63 8.2k 0.7× 5.8k 0.6× 7.5k 0.8× 3.5k 0.5× 12.5k 2.5× 158 34.8k
James R. Wright Canada 98 8.1k 0.7× 11.2k 1.1× 4.0k 0.4× 2.9k 0.4× 2.5k 0.5× 1.0k 39.1k
Simon G. Thompson United Kingdom 78 6.8k 0.6× 14.5k 1.5× 16.4k 1.7× 4.3k 0.7× 13.1k 2.6× 223 90.9k
Lars Holmberg Sweden 81 11.8k 1.0× 9.9k 1.0× 4.7k 0.5× 3.6k 0.5× 2.2k 0.4× 533 31.9k
Lesley Stewart United Kingdom 48 7.9k 0.7× 10.0k 1.0× 8.8k 0.9× 2.4k 0.4× 5.5k 1.1× 140 51.7k
Nan M. Laird United States 78 5.5k 0.5× 6.7k 0.7× 9.0k 0.9× 2.9k 0.4× 7.1k 1.4× 240 68.9k
Terry M. Therneau United States 107 7.5k 0.6× 5.5k 0.6× 10.1k 1.0× 3.7k 0.6× 15.6k 3.1× 403 58.1k

Countries citing papers authored by Paul Meier

Since Specialization
Citations

This map shows the geographic impact of Paul Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Meier more than expected).

Fields of papers citing papers by Paul Meier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Meier. The network helps show where Paul Meier may publish in the future.

Co-authorship network of co-authors of Paul Meier

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Meier. A scholar is included among the top collaborators of Paul Meier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Meier. Paul Meier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyer, Kenneth M., Ellen Holfels, Nancy Roizen, et al.. (2005). Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. American Journal of Obstetrics and Gynecology. 192(2). 564–571. 176 indexed citations
2.
Meier, Paul, et al.. (2003). Prevention of Iron Deficiency Anemia in Adolescent and Adult Pregnancies. Clinical Medicine & Research. 1(1). 29–36. 73 indexed citations
3.
McLeod, Rima, Kenneth M. Boyer, Nancy Roizen, et al.. (2000). The child with congenital toxoplasmosis.. PubMed. 20. 189–208. 20 indexed citations
4.
Rose, Eric A., Alan J. Moskowitz, Milton Packer, et al.. (1999). The REMATCH trial: rationale, design, and end points. The Annals of Thoracic Surgery. 67(3). 723–730. 249 indexed citations
5.
Bigger, J. Thomas, Michael K. Parides, Linda Rolnitzky, et al.. (1998). Changes in Sample Size and Length of Follow-up to Maintain Power in The Coronary Artery Bypass Graft (CABG) Patch Trial. Controlled Clinical Trials. 19(1). 1–14. 5 indexed citations
6.
Mets, Marilyn B., Ellen Holfels, Kenneth M. Boyer, et al.. (1996). Eye Manifestations of Congenital Toxoplasmosis. American Journal of Ophthalmology. 122(3). 309–324. 151 indexed citations
7.
Roizen, Nancy, Charles N. Swisher, Joyce Hopkins, et al.. (1995). Neurologic and Developmental Outcome in Treated Congenital Toxoplasmosis. PEDIATRICS. 95(1). 11–20. 88 indexed citations
8.
McGee, Therese, Laszlo Stein, Nina Kraus, et al.. (1992). Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis. Otolaryngology. 106(1). 75–80. 40 indexed citations
9.
Meier, Paul. (1991). Compliance as an Explanatory Variable in Clinical Trials: Comment. Journal of the American Statistical Association. 86(413). 19–19. 22 indexed citations
10.
Beach, Michael L. & Paul Meier. (1989). Choosing covariates in the analysis of clinical trials. Controlled Clinical Trials. 10(4). 161–175. 69 indexed citations
11.
Meier, Paul. (1986). Damned Liars and Expert Witnesses. Journal of the American Statistical Association. 81(394). 269–276. 35 indexed citations
12.
Klimt, Christian R., Genell L. Knatterud, Jeremiah Stamler, & Paul Meier. (1986). Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin. Journal of the American College of Cardiology. 7(2). 251–269. 183 indexed citations
13.
Meier, Paul, Jerome Sacks, & S. L. Zabell. (1984). What Happened inHazelwood: Statistics, Employment Discrimination, and the 80% Rule. American Bar Foundation Research Journal. 9(1). 139–186. 23 indexed citations
14.
Meier, Paul. (1979). Terminating a trial—the ethical problem. Clinical Pharmacology & Therapeutics. 25(5part2). 633–640. 40 indexed citations
15.
Meier, Paul. (1975). Statistics and Medical Experimentation. Biometrics. 31(2). 511–511. 88 indexed citations
16.
Meier, Paul, et al.. (1967). Statistical evaluation of reaction mechanisms in immune hemolysis—I The dose response of the second component of complement. Immunochemistry. 4(6). 419–429. 10 indexed citations
17.
Griem, Melvin L., Paul Meier, & Glen D. Dobben. (1967). Analysis of the Morbidity and Mortality of Children Irradiated in Fetal Life. Radiology. 88(2). 347–349. 21 indexed citations
18.
Kaplan, Edward L. & Paul Meier. (1958). Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. 53(282). 457–481. 33599 indexed citations breakdown →
19.
Kaplan, Edward L. & Paul Meier. (1958). Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. 53(282). 457–457. 6608 indexed citations breakdown →
20.
Meier, Paul. (1957). Safety Testing of Poliomyelitis Vaccine. Science. 125(3257). 1067–1071. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026